EASL is an association dedicated to the pursuit of excellence in liver research and in the clinical practice of liver disorders. EASL is governed by a board of 11 experts; the Secretary General, Vice-Secretary, Treasurer, 5 Scientific Committee members, 2 Educational Councillors, and the EU Policy Councillor all actively engaged and involved in the discipline.
Prof. Markus Peck-Radosavljevic, MD, Secretary General of EASL, is Associate Professor of Medicine and Vice-Chairman at the Department of Gastroenterology and Hepatology at the Medizinische Universität Wien (MedUniWien), Austria. He is a fellow of the Austrian College of Physicians (Internal Medicine, Gastroenterology / Hepatology, Infectious Diseases, and Intensive Care Medicine) and member of several professional organisations including the American Association for the Study of Liver Disease (AASLD), the European Association for the Study of the Liver (EASL), the American Gastroenterologic Association (AGA), the Austrian Transplant Association, the Austrian Society for Infectious Diseases, and the Austrian Association for Gastroenterology and Hepatology.
Prof. Peck started out his research in liver disease with the complications of portal hypertension and cirrhosis including the hematologic abnormalities. He has published several reports on thrombocytopenia and thrombopoietin in liver disease and liver transplantation and later more on the hematologic side effects of antiviral therapy in chronic hepatitis C. He has been co-investigator in trial of pegInterferon in liver transplant patients and principal investigator in trials of pegIFN in hemodialysis patients with chronic hepatitis C or combination antiviral therapy in HIV/HCV coinfected patients.
For the past years, he has been head of the Portal Hypertension and HCC Study Group at the MedUniWien. Currently he is engaged in mostly clinical, but also some basic research in advanced stage liver disease, including problems related to portal hypertension, viral hepatitis, and hepatocellular carcinoma, where he is conducting several clinical trials. He is also currently the Secretary General of the Austrian Association for Internal Medicine.
Prof. Peck will step down from his position as Secretary General of EASL in 2015 at The International Liver Congress.
Dr Laurent Castera, MD, PhD, Vice-Secretary of EASL, graduated from Paris Medical School in 1987 and completed his residency in Hepatology and Gastroenterology in Assistance Publique-Hôpitaux de Paris until 1993 when he received his Medical degree from the University of Paris-VI. He further completed his training in Hepatology as Assistant Professor in the department of Hepatology and Gastroenterology at the University of Paris-XI (Hôpital Bicêtre) until 1997. He then spent three years as a research fellow at the INSERM Unit 99 in Prof. Jean-Michel Pawlotsky’s laboratory (Hôpital Henri Mondor, Créteil) where he worked on different aspects of hepatitis viruses resistance to antiviral therapy using a quasispecies approach.
Laurent Castera earned his Doctoral degree in Biochemistry and Molecular Biology from the University of Paris-XII in 2007. Meanwhile, he was appointed Médecin des Hôpitaux in 2001 and moved to the department of Hepatology and Gastroenterology of the University Hospital of Bordeaux where he started to develop clinical research on novel approaches for the non-invasive evaluation of liver fibrosis based on the measurement of liver stiffness using transient elastography.
In 2011, Dr Castera joined the department of Hepatology at the University of Paris-VII (Hôpital Beaujon, Clichy) to take the lead of the non-invasive methods and the HCC group. The same year he organised the EASL Monothematic Conference on Evaluation of Disease Severity and Prognosis in Chronic Liver Disease with Prof. Massimo Pinzani.
Laurent Castera is member of the American Association for the Study of Liver Disease (AASLD) and of the French Association for the Study of the Liver (AFEF). He serves on the editorial boards of the Journal of Hepatology and Gut and as a member of the Scientific Committee of the United European Gastroenterology (UEG) since 2011. He became member of the EASL Governing Board in April 2012 and is currently serving as Vice-Secretary of EASL.
Prof. Mauro Bernardi, EASL Treasurer, graduated in Medicine at the University of Bologna in 1972. He completed his residency in Gastroenterology and then Internal Medicine at the Universities of Bologna and Chieti from 1972 to 1978.
He was appointed as Assistant Professor in Internal Medicine at Chieti (1974-1978) and Bologna Universities (1978-1983). He spent 1975 in the Liver Research Unit of King’s College Hospital, London (Prof. R. Williams), as a locum research fellow, where he started his research activity on renal function abnormalities in cirrhosis under the guidance of Dr. S.P. Wilkinson.
Mauro Bernardi was appointed as Associate Professor in Internal Medicine in 1983 at Bologna University. He was visiting professor at Technion, Haifa, in 1984. In 1995, he became full Professor of Internal Medicine at Bologna University.
Since 1997, he has been heading a Unit of Internal Medicine at Policlinico S. Orsola-Malpighi, University of Bologna. From 2000 to 2006, he was director of the Department of Internal Medicine, Cardioangiology and Hepatology, at Bologna University. His teaching activity is devoted to the students of the medical school and post-graduate courses in Internal Medicine, Gastroenterology and Infectious Diseases.
He was member of the Scientific Committee of the Italian Association for the Study of the Liver from 1978 to 1982, and member of the governing Board of EASL from 1990 to 1993. He started his duty as EASL Treasurer in April 2009. He is and has been a member of the Editorial Boards of Digestive and Liver Disease (2001-04; 2008 – current), and Journal of Hepatology (1995-1999).
His main research fields are represented by cirrhosis and related complications (renal function abnormalities, ascites, and cardiovascular abnormalities), hepatocellular carcinoma, chronic viral hepatitis, and liver transplantation, but also include clinical aspects and treatment of alcoholism, and pathophysiology and prevention of experimental ischemia-reperfusion damage of the liver.
If you wish to find out more about the other members of the EASL Governing Board please click on their pictures below.